Q2 Earnings: TAVR leads Edwards' to nearly 18% revenue growth
This article was originally published in Clinica
Executive Summary
Sales of Edwards Lifesciences' Sapien transcatheter aortic valves grew 42.2% year-over-year in the second quarter of 2015, driving the company's overall revenues up 17.7% on operational basis.